Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cotton

Showing results (431-440 of 474) with videos related to

Pageof 48
Sort By:
The Pediatric Infectious Disease Journal|February 8, 2022
The Impact of Interventions to Prevent Neonatal Healthcare-associated Infections in Low- and Middle-income Countries: A Systematic ReviewFelicity C Fitzgerald, Walter Zingg, Gwendoline Chimhini, et al.
The Lancet. HIV|December 9, 2021
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation studyAdrie Bekker, Edmund V Capparelli, Avy Violari, et al.
Revue Neurologique|October 13, 2020
MRI characteristics of MOG-Ab associated disease in adults: An updateN Shor, R Deschamps, A Cobo Calvo, et al.
Mbio|April 9, 2021
Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in ChildrenMichael J Bale, Mary Grace Katusiime, Daria Wells, et al.
The Lancet. Child & Adolescent Health|July 24, 2021
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trialAditya H Gaur, Mark F Cotton, Carina A Rodriguez, et al.
The Journal of Clinical Investigation|September 12, 2017
No evidence of HIV replication in children on antiretroviral therapyGert U Van Zyl, Mary Grace Katusiime, Ann Wiegand, et al.
European Journal of Immunology|April 10, 2022
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patientsStanley Kimbung Mbandi, Hannah Painter, Adam Penn-Nicholson, et al.
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2019
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency VirusMichael J Boivin, Miriam Chernoff, Lee Fairlie, et al.
Pageof 48

Showing results (431-440 of 474) with videos related to

Sort By:
Pageof 48
The Pediatric Infectious Disease Journal|February 8, 2022
The Impact of Interventions to Prevent Neonatal Healthcare-associated Infections in Low- and Middle-income Countries: A Systematic ReviewFelicity C Fitzgerald, Walter Zingg, Gwendoline Chimhini, et al.
The Lancet. HIV|December 9, 2021
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation studyAdrie Bekker, Edmund V Capparelli, Avy Violari, et al.
Revue Neurologique|October 13, 2020
MRI characteristics of MOG-Ab associated disease in adults: An updateN Shor, R Deschamps, A Cobo Calvo, et al.
Mbio|April 9, 2021
Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in ChildrenMichael J Bale, Mary Grace Katusiime, Daria Wells, et al.
The Lancet. Child & Adolescent Health|July 24, 2021
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trialAditya H Gaur, Mark F Cotton, Carina A Rodriguez, et al.
The Journal of Clinical Investigation|September 12, 2017
No evidence of HIV replication in children on antiretroviral therapyGert U Van Zyl, Mary Grace Katusiime, Ann Wiegand, et al.
European Journal of Immunology|April 10, 2022
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patientsStanley Kimbung Mbandi, Hannah Painter, Adam Penn-Nicholson, et al.
The Lancet. HIV|November 26, 2020
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept studyTheodore D Ruel, Edmund V Capparelli, Camlin Tierney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of LifeBryan S Nelson, Camlin Tierney, Deborah Persaud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2019
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency VirusMichael J Boivin, Miriam Chernoff, Lee Fairlie, et al.
Pageof 48